🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Argentinian Prospective Registry of Patients With Lupus

Recruitingn/aAges 18 Years - anyAllSociedad Argentina de Reumatologia
NCT05470569 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In Latin America, information about patients with systemic lupus erythematosus (SLE) is limited. Multicenter studies are needed to obtain "real world data '' and to carry out longer follow-ups. The purpose of this project is to design a cohort of Argentinian patients with SLE to describe "our real setting" and to identify possible limitations in access to specialized consultations and treatments.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients ≥ 18 years of age * Classified as SLE (according to the 1982/1997 American College of Rheumatology criteria and/or Systemic Lupus International Collaborating Clinics criteria for SLE) * Less than 5 years from meeting SLE criteria * Informed consent signature Exclusion Criteria: * Diagnosis of other systemic autoimmune diseases or overlap syndromes * Patients who have been transferred to other centers
💊

What it tests

  • Not listed
📍

Where

1 site
Lucila Garcia
La Plata, Argentina
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy